Pleural Space | Conversations in Lung Cancer

Stigma and Nihilism in Lung Cancer Care and Control (Part 2)

Dr. Jamie Studts continues the conversation about stigma and nihilism from the clinician scientist perspective with Dr. Jamie S. Ostroff and Dr. Lisa Carter-Harris, including how language contributes to stigma and the new International Association for the Study of Lung Cancer (IASLC) language guide.
Jamie L. Studts, PhD, FSBM, is a Professor of Medical Oncology at the University of Colorado School of Medicine and Scientific Director of Behavioral Oncology. Dr. Studts also serves as the Chair for the NLCRT’s Survivorship, Stigma, and Nihilism Task Group. Jamie S. Ostroff, PhD, is a behavioral scientist and the Chief of the Psychiatry & Behavioral Sciences service at Memorial Sloan Kettering Cancer Center. Dr. Ostroff is the current Joseph Gaumont Chair of Cancer Prevention. Lisa Carter-Harris, PhD, APRN, ANP-C, FAAN, is a nurse practitioner and behavioral scientist and serves as the Director of the Tobacco Cessation Research Program at Memorial Sloan Kettering in the Department of Psychiatry & Behavioral Sciences.
As a follow-up to the National Lung Cancer Roundtable and American College of Radiology’s 2021 webinar series, the “Power of Partnerships” limited podcast series will feature conversations currently happening in the world of lung cancer with the people pushing the field into the future.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.

Stigma and Nihilism in Lung Cancer Care and Control (Part 1)

"The Power of Partnerships” limited podcast series will feature conversations currently happening in the world of lung cancer with the people pushing the field into the future.
 
Dr. Jamie Studts and patient advocates Jill Feldman and Jim Pantelas discuss stigma surrounding lung cancer from internal and external sources and the work being done to combat stigma.
 
Jamie L. Studts, PhD, FSBM, is a Professor of Medical Oncology at the University of Colorado School of Medicine and Scientific Director of Behavioral Oncology. Dr. Studts also serves as the Chair for the NLCRT’s Survivorship, Stigma, and Nihilism Task Group.  Jill Feldman has been a life-long patient advocate, working with organizations like the LUNGevity Foundation, Go2 Foundation for Lung Cancer, and is the cofounder of EGFR, a patient community for patients diagnosed with EGFR positive lung cancer. Jim Pantelas is a 15-year cancer survivor and navy veteran who has partnered with the Go2 Foundation for Lung Cancer to lobby Capitol Hill for increased funding for lung cancer research and early detection programs.
 
Additional information on this episode’s topic and guests, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources. Access the recordings of the 2021 webinar series that inspired this podcast series at https://pages.acr.org/2021-NLCRT-Webinar-Series.html.

Mythbusting LCS Eligibility: Impact of COVID on Lung Cancer Screening (Part 5)

*This episode was originally part of the ACR Bulletin podcast and was recorded in Fall 2020. For the most up to date COVID-19 guidelines, please contact your local screening center.
Dr. Debra Dyer, MD, finishes her conversation with Dr. Patricia Rivera, MD, with a discussion on the impact of the COVID-19 pandemic on lung cancer screening.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Dr. Patricia Rivera is a Professor of Medicine in the Division of Pulmonary Diseases and Critical Care Medicine at the University of North Carolina at Chapel Hill. Dr. Rivera currently serve as Co-Director of the Multidisciplinary Thoracic Oncology Program and Director of the Lung Cancer Screening Program at UNC. She serves as Secretary-Treasurer of the American Thoracic Society and will serve as President of ATS in 2023. She is a member of the National Lung Cancer Roundtable and serves as Vice-Chair of the Lung Cancer in Women and the Biomarker Task Forces.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.

Mythbusting LCS Eligibility: Biomarker Testing (Part 4)

*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020.
For part four of their discussion, Dr. Debra Dyer, MD, and Dr. Patricia Rivera, MD, discuss the importance of biomarker testing for patients with advanced NSCLC.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Dr. Patricia Rivera is a Professor of Medicine in the Division of Pulmonary Diseases and Critical Care Medicine at the University of North Carolina at Chapel Hill. Dr. Rivera currently serve as Co-Director of the Multidisciplinary Thoracic Oncology Program and Director of the Lung Cancer Screening Program at UNC. She serves as Secretary-Treasurer of the American Thoracic Society and will serve as President of ATS in 2023. She is a member of the National Lung Cancer Roundtable and serves as Vice-Chair of the Lung Cancer in Women and the Biomarker Task Forces.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.

Mythbusting LCS Eligibility: USPSTF Guidelines (Part 3)

*This episode was originally part of the ACR Bulletin podcast and recorded in 2020. For the most up to date information on USPSTF coverage, please visit the ACR website for the list of private payer that have adopted the criteria.
In part three of this series, Dr. Debra Dyer, MD, and Dr. Patricia Rivera, MD, discuss the proposed USPSTF lung cancer screening guidelines.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Dr. Patricia Rivera is a Professor of Medicine in the Division of Pulmonary Diseases and Critical Care Medicine at the University of North Carolina at Chapel Hill. Dr. Rivera currently serve as Co-Director of the Multidisciplinary Thoracic Oncology Program and Director of the Lung Cancer Screening Program at UNC. She serves as Secretary-Treasurer of the American Thoracic Society and will serve as President of ATS in 2023. She is a member of the National Lung Cancer Roundtable and serves as Vice-Chair of the Lung Cancer in Women and the Biomarker Task Forces.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.

Mythbusting LCS Eligibility: COVID-19 and Lung Cancer Screening (Part 2)

*This episode was originally part of the ACR Bulletin podcast and was recorded in Fall 2020. For the most up to date COVID-19 guidelines, please contact your local screening center.
Dr. Debra Dyer, MD, and Dr. Patricia Rivera, MD, continue their conversation by discussing the impact COVID-19 has had on lung cancer screening programs across the country.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Dr. Patricia Rivera is a Professor of Medicine in the Division of Pulmonary Diseases and Critical Care Medicine at the University of North Carolina at Chapel Hill. Dr. Rivera currently serve as Co-Director of the Multidisciplinary Thoracic Oncology Program and Director of the Lung Cancer Screening Program at UNC. She serves as Secretary-Treasurer of the American Thoracic Society and will serve as President of ATS in 2023. She is a member of the National Lung Cancer Roundtable and serves as Vice-Chair of the Lung Cancer in Women and the Biomarker Task Forces.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.

Mythbusting LCS Eligibility: Disparities (Part 1)

*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020.
Dr. Debra Dyer, MD, has a conversation with Dr. Patricia Rivera, MD, about disparities in eligibility criteria for, access to, and implementation of lung cancer screening in part one of a five-part conversation.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Dr. Patricia Rivera is a Professor of Medicine in the Division of Pulmonary Diseases and Critical Care Medicine at the University of North Carolina at Chapel Hill. Dr. Rivera currently serves as Co-Director of the Multidisciplinary Thoracic Oncology Program and Director of the Lung Cancer Screening Program at UNC. She serves as Secretary-Treasurer of the American Thoracic Society and will serve as President of ATS in 2023. She is a member of the National Lung Cancer Roundtable and serves as Vice-Chair of the Lung Cancer in Women and the Biomarker Task Forces.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.

Mythbusting LCS in Nursing: Lung Cancer and COVID-19 (Part 4)

*This episode was originally part of the ACR Bulletin podcast and was recorded in Fall 2020. For the most up to date COVID-19 guidelines, please contact your local screening center.
In the final piece of their four-part discussion, Dr. Debra Dyer, MD, and nurse navigator Linda Dowling, RN, discuss lung cancer screening amidst the COVID-19 pandemic.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Linda Dowling was a nurse navigator at Rush University Medical Center. After obtaining her BSN, Linda focused her career on outpatient oncology and thoracic nurse navigation, including implementing and growing Rush’s lung screening program and helping form the Tobacco Oversight Committee. Since this interview was recorded, she has retired from nursing.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.

Mythbusting LCS in Nursing: The Patients (Part 3)

*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020.
Dr. Debra Dyer, MD, and nurse navigator Linda Dowling, RN, talk about what patients should know about lung cancer screening in part three of their four-part discussion.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Linda Dowling was a nurse navigator at Rush University Medical Center. After obtaining her BSN, Linda focused her career on outpatient oncology and thoracic nurse navigation, including implementing and growing Rush’s lung screening program and helping form the Tobacco Oversight Committee. Since this interview was recorded, she has retired from nursing.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.

Mythbusting LCS in Nursing: Misconceptions of the Screening Process (Part 2)

*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020.
Dr. Debra Dyer, MD, and nurse navigator Linda Dowling, RN, discuss the myths surround the lung cancer screening process in part two of their conversation.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Linda Dowling was a nurse navigator at Rush University Medical Center. After obtaining her BSN, Linda focused her career on outpatient oncology and thoracic nurse navigation, including implementing and growing Rush’s lung screening program and helping form the Tobacco Oversight Committee. Since this interview was recorded, she has retired from nursing.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.